Skip to content

To analyze the effect of perioperative rehabilitation intervention on the clinical outcome of patients undergoing gastrointestinal cancer surgery based on the assessment of muscle function

To analyze the effect of perioperative rehabilitation intervention on the clinical outcome of patients undergoing gastrointestinal cancer surgery based on the assessment of muscle function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094230
Enrollment
Unknown
Registered
2024-12-19
Start date
2024-12-27
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal tumors

Interventions

Intervention group:Aerobics
Control group:Routine education in gastrointestinal surgery

Sponsors

The Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: a) Patients with gastrointestinal tumors who are clinically scheduled to undergo gastrointestinal surgery, aged between 18-70 years; b) Pathological stage T is 1~3 stage, N is 0 or 1 stage, M is 0 stage; c) Patients with preoperative cardiac function NYHA grade <= III.; d) Patients who can tolerate getting out of bed and walking on flat ground before surgery; e) Normal cognitive function and ability to cooperate with rehabilitation training; f) Agree to participate in this trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: a) Patients with severe limb mobility impairment who cannot cooperate with rehabilitation training; b) Patients with other severe hepatic and renal insufficiency who cannot tolerate training; c) Patients with pacemaker implantation who cannot cooperate with body composition measurement; d) Patients with preoperative cardiac function NYHA grade >= IV; e) Patients with severe cognitive impairment or psychiatric disorders; f) Patients who refuse to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Skeletal muscle mass;

Secondary

MeasureTime frame
6 meter walk test;5 sit-up tests;Albumin;Haemoglobin;Interleukin-6;TNF-a;Postoperative complications;Quality of life;Anxiety and Depression Scale;C-reactive protein;Procalcitonin;

Countries

China

Contacts

Public ContactXiang Jie

The Affiliated Hospital of Xuzhou Medical University

Xj1111@163.com+86 137 7597 0412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026